Kevin King

Partner
Full contact info

Experience

ArsenalBio Closes Oversubscribed $325 Million Series C

September 4, 2024

Cooley advised Arsenal Biosciences (ArsenalBio), a clinical-stage programmable cell therapy company focused on engineering advanced chimeric antigen receptor T-cell (CAR-T) therapies for solid tumors, on the close of its oversubscribed $325 million Series C financing round.

Read more

Related contacts

Josh Seidenfeld
Partner, Palo Alto
Sara Semnani
Partner, Santa Monica
Megan Browdie
Partner, Washington, DC
Annie Froehlich
Partner, Washington, DC
Dr. Kate Hillier
Partner, Palo Alto
Christopher Kimball
Partner, Washington, DC
Kevin King
Partner, Washington, DC
John Sellers
Partner, Palo Alto
Shannon MacMichael
Special Counsel, Washington, DC
Julia Gage
Associate, San Francisco
William Beom Hong
Associate, Palo Alto
Emily Lee
Associate, Palo Alto
Megan Stallworth
Associate, Palo Alto
Rubin Waranch
Associate, Colorado
Jake Ironfield
Transactional Quantitative Analyst, New York

Related Practices & Industries

Grafana Labs Completes $270 Million Primary and Secondary Transaction

August 21, 2024

Cooley advised Grafana Labs, the company behind ubiquitous, open and composable operational dashboards, on the successful completion of its approximately $270 million primary and secondary transaction.

Read more

Related contacts

Kevin Rooney
Partner, San Francisco
Rachel M. Burns
Special Counsel, San Francisco
Rachel Lydon
Associate, San Diego
Alanna Anderson
Associate, Palo Alto
Melanie Yuvienco
Paralegal Specialist, Palo Alto
Sharon Connaughton
Special Counsel, Washington, DC
Rebecca Ross
Special Counsel, Washington, DC
Christopher Kimball
Partner, Washington, DC
Kevin King
Partner, Washington, DC
John Sellers
Partner, Palo Alto
Karen Tsai
Special Counsel, Washington, DC
Jane Jun
Associate, Palo Alto
Natalie D. Vernon
Associate, Colorado
Jake Ironfield
Transactional Quantitative Analyst, New York

Related Practices & Industries

Abnormal Security Announces $250 Million Series D at a $5.1 Billion Valuation

August 6, 2024

Cooley advised Abnormal Security, the leader in AI-native human behavior security, on its $250 million Series D financing at a $5.1 billion valuation.

Read more

Related contacts

Josh Seidenfeld
Partner, Palo Alto
Charles Haley
Partner, Palo Alto
Christopher Kimball
Partner, Washington, DC
Kevin King
Partner, Washington, DC
Amanda A. Main
Partner, Palo Alto
Howard Morse
Partner, Washington, DC
Matthew Schwee
Partner, Reston
John Sellers
Partner, Palo Alto
Milson Yu
Partner, Palo Alto
Mark Windfeld-Hansen
Senior Counsel, Palo Alto
Sharon Connaughton
Special Counsel, Washington, DC
Karen Tsai
Special Counsel, Washington, DC
Julie Wicklund
Special Counsel, Palo Alto
William Beom Hong
Associate, Palo Alto
Gary Warren Hunt III
Associate, Washington, DC
Yuehui Ji
Associate, Palo Alto
Tiffany Le
Associate, Palo Alto
Daniel Y. Lee
Associate, Palo Alto
Yichen Liu
Associate, Palo Alto
Nan Yang
Associate, Palo Alto
Zi Ye
Associate, Palo Alto
Katie Kissner
Quantitative Analyst, San Francisco

Related Practices & Industries

GrayMatter Robotics Announces $45 Million Series B

June 20, 2024

Cooley advised GrayMatter Robotics, an artificial intelligence-powered robotics leader empowering humans with intelligent automation, on its $45 million Series B financing.

Read more

Related contacts

Dave Young
Partner, Santa Monica
Sean O'Neill
Associate, Santa Monica
James H. Reizman
Associate, Santa Monica
Rebecca Ross
Special Counsel, Washington, DC
Kevin King
Partner, Washington, DC
Christopher Kimball
Partner, Washington, DC
John Paul Oleksiuk
Partner, New York
John Sellers
Partner, Palo Alto

Related Practices & Industries

Jiangsu Hengrui Pharmaceuticals Out-Licenses GLP-1 Portfolio

May 17, 2024

Cooley advised Jiangsu Hengrui Pharmaceuticals, one of the largest pharmaceutical companies in China, on its licensing of global rights (excluding Greater China) for the development, production and commercialization of three of its proprietary glucagon-like peptide-1 (GLP-1) drugs to Hercules CM Newco, a newly established Delaware company.

Read more

Related contacts

Bill Christiansen
Partner, Seattle
Sharon Connaughton
Special Counsel, Washington, DC
Annie Froehlich
Partner, Washington, DC
Zack Gong
Associate, Shanghai
Kevin King
Partner, Washington, DC
Edmond Lay
Associate, San Diego
Howard Morse
Partner, Washington, DC
Sarah Oliai
Associate, Washington, DC
W. Chad Shear
Partner, San Diego
Michael Shen
Counsel, Shanghai
Dr. Xixi Sun
Associate, Boston
Alan W. Tamarelli
Partner, New York
Karen Tsai
Special Counsel, Washington, DC
Ivy Wang
Associate, Shanghai
Bin Wang
Special Counsel, Palo Alto
Letian Wei
Legal Consultant, Shanghai
Dr. Heng Zhang
Patent Agent , Boston
Dr. Tian Yong Zheng
Patent Agent, Seattle
Joanna Zhang
Associate, San Diego

Related Practices & Industries

View more

Admissions and credentials

District of Columbia

Rankings and accolades

Chambers USA: International Trade: Export Controls & Economic Sanctions – Nationwide (2020 – 2024)

The Legal 500 US: Leading Lawyer in Customs, Export Controls, and Economic Sanctions (2023)

Kevin is a fantastic resource, counsel, and business adviser who has built an exceptionally deep team.

Chambers USA 2023

He translates the very complex topic of sanctions and export controls into clear information and pragmatic advice that can be implemented in a business context.

Chambers USA 2023